BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28447926)

  • 21. High-dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China.
    Chen C; Sun P; Cui J; Yan S; Chen H; Xia Y; Bi X; Liu P; Wang Y; Yang H; Nie M; Zhang XW; Jiang W; Li ZM
    Cancer Med; 2019 Apr; 8(4):1359-1367. PubMed ID: 30821418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.
    Wong ET; Tishler R; Barron L; Wu JK
    Cancer; 2004 Jul; 101(1):139-45. PubMed ID: 15221999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus-positive mucocutaneous ulcer arising in a post-hematopoietic cell transplant patient followed by polymorphic posttransplant lymphoproliferative disorder and cytomegalovirus colitis.
    Satou A; Kohno A; Fukuyama R; Elsayed AA; Nakamura S
    Hum Pathol; 2017 Jan; 59():147-151. PubMed ID: 27569297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus-positive post-transplant lymphoproliferative disorder of the central nervous system, after renal transplantation with a discrepancy in viral load between peripheral blood and cerebrospinal fluid.
    Boersma MN; van der Zanden A; Laverman GD; Sanders JS; de Vries PA
    Transpl Int; 2012 Nov; 25(11):e113-6. PubMed ID: 22909403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?
    Gibson SE; Swerdlow SH; Craig FE; Surti U; Cook JR; Nalesnik MA; Lowe C; Wood KM; Bacon CM
    Am J Surg Pathol; 2011 Jun; 35(6):807-15. PubMed ID: 21552113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma.
    Sun X; Liu J; Wang Y; Bai X; Chen Y; Qian J; Zhu H; Liu F; Qiu X; Sun S; Ji N; Liu Y
    Oncotarget; 2017 Jul; 8(30):49156-49164. PubMed ID: 28467782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral Lymphoma in a Kidney Transplant: A Case Report.
    Guglielmo N; Levi Sandri GB; Melandro F; Garofalo M; Poli L; Berloco P
    Exp Clin Transplant; 2015 Dec; 13(6):600-2. PubMed ID: 26030159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of central nervous system lymphoma following transplantation using monoclonal antibody and ganciclovir].
    Hansen PB; Al-Farra G
    Ugeskr Laeger; 2010 Oct; 172(42):2907-8. PubMed ID: 21040668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Solid Mass in the Chest Wall.
    Alagoz S; Yalin SF; Gulcicek S; Ozgur N; Altiparmak MR; Seyahi N
    Prog Transplant; 2016 Dec; 26(4):386-388. PubMed ID: 27555070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-transplant lymphoproliferative disorder after kidney transplantation: time to adopt monitoring of Epstein-Barr virus?
    Biller P; Michaux L; Pauw LD; Camboni A; Mourad M; Kanaan N
    Acta Clin Belg; 2015 Jun; 70(3):218-22. PubMed ID: 25541210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
    Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
    Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab, Dexamethasone, Cytarabine, and Cisplatin as Effective Platinum-Based Salvage Chemotherapy for Periportal Posttransplant Lymphoproliferative Disorder After an Orthotopic Liver Transplant.
    Beal EW; Bennett S; Silski LS; Whitson B; Henry M; Black S
    Exp Clin Transplant; 2015 Oct; 13(5):475-8. PubMed ID: 25184436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry.
    Mocikova H; Pytlik R; Sykorova A; Janikova A; Prochazka V; Vokurka S; Berkova A; Belada D; Campr V; Buresova L; Trneny M;
    Leuk Lymphoma; 2016 Dec; 57(12):2777-2783. PubMed ID: 27087066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of high-dose etoposide cytarabine as consolidation following rituximab methotrexate temozolomide induction in newly diagnosed primary central nervous system lymphoma in immunocompetent patients.
    Birsen R; Willems L; Pallud J; Blanc E; Burroni B; Legoff M; Le Ray E; Pilorge S; Deau B; Franchi P; Vignon M; Kirova Y; Edjlali M; Houillier C; Soussain C; Varlet P; Dezamis E; Damotte D; Bouscary D; Tamburini J
    Haematologica; 2018 Jul; 103(7):e296-e299. PubMed ID: 29472354
    [No Abstract]   [Full Text] [Related]  

  • 36. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S; Zafar MN; Best J; Reddy HK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
    Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small Intestine Posttransplant Lymphoproliferative Disorder in a Kidney Transplant Recipient: A Case Report.
    Radunovic D; Dapcevic M; Prelevic V; Tomovic F; Ratkovic M; Basic-Jukic N
    Exp Clin Transplant; 2021 Jan; 19(1):77-79. PubMed ID: 33441059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr Virus-Associated Nodal Marginal Zone Lymphoma: Part of the Spectrum of Posttransplant Lymphoproliferative Disorder?
    Cheung CY; Lau WH; Cheuk W
    Int J Surg Pathol; 2019 Feb; 27(1):94-97. PubMed ID: 29944019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttransplant lymphoproliferative disorder in renal transplant recipients: Experience from a Tertiary Care Center.
    Gupta D; Mendonca S; Tewari R; Ahuja A; Singh L; Joshi A; Chatterjee T
    Saudi J Kidney Dis Transpl; 2021; 32(2):418-427. PubMed ID: 35017336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.